Pub Date : 1900-01-01DOI: 10.5455/ijbh.2022.10.176-182
Bobana Petrovic, Alma Biscevic, M. Pjano, Ajla Salkica
Background: A cataract is a type of degenerative change of the lens, which is characterized by the clouding of the lens followed by symptoms of optical deterioration. Over 70 years ago, Sir Harold Ridley implanted the first useable modern-day intraocular lens (IOL) implant. A lot has happened since then. The IOL is arguably the most life-changing and innovative implant in the history of medicine. Currently, there are several types of intraocular lenses on the market. The main classification could be monofocal lenses, multifocal, trifocal, extended depth of focus (EDOF) lenses, and toric lenses. Objective: The aim of this case report is to report the importance of IOL selection in patients with young-age cataracts. Case report: A 35-year-old patient presented first time at our Clinic. In the last six months, he noticed poor vision in his left eye, even with spectacles. The right eye was operated on in another institution in 2020, due to the presence of a young-age cataract. After a complete preoperative ophthalmological examination, we discovered the presence of a cataract in the left eye. UDVA of the left eye was 0.4, and CDVA was +0.50/+0.50/30°=0.5. UNVA and DCNVA was J2. We decided to implant TECNIS Synergy™ IOL (Johnson & Johnson Vision, Santa Ana, CA, USA) during the cataract surgery. That EDOF IOL bridges the gap between the performance of monofocal and multifocal IOLs and delivers continuous high-contrast vision for patients with cataracts from far through near, even in low-light conditions. There were no intraoperative or postoperative complications. On a 7-day, check-up UDVA of the left eye was 1.0, and UNVA was J1. The patient was satisfied with the vision in the left eye, so he wanted to correct the vision of the right eye which was implanted with SENSAR® IOL (Johnson & Johnson Vision, Santa Ana, CA, USA), with a residual diopter of +2.00/+1.00/120 for distance, and +4.50/+1.00/120 for near vision. This choice of IOL in the other institution was not an ideal solution for this patient due to his young age and occupation. The capsular bag was already in slight fibrosis, so the explantation of the existing IOL and implantation of the new one was not a reasonable option. We decided to go with the multifocal AddOn® toric lens (1stQ GmbH, Mannheim, Germany), the refractive-surgery platform for vision enhancement of pseudophakic eyes, that also correct residual astigmatism. On a 7-day check-up, this patient’s UDVA was 1.0 and UNVA was J1. The result was a happy patient, who could go back to his everyday life without spectacle independence. Conclusion: Good unaided distance visual acuity (VA) is now a realistic expectation following cataract surgery and intraocular lens (IOL) implantation. We should be aware of patient expectations and demands, especially when having a patient with young-age cataracts. Often more time should be spent on preoperative IOL planning than cataract surgery itself.
背景:白内障是一种晶状体的退行性改变，其特征是晶状体混浊，随后出现光学退化症状。70多年前，哈罗德·雷德利爵士植入了第一个可用的现代人工晶状体(IOL)。从那以后发生了很多事情。人工晶状体可以说是医学史上最能改变生活、最具创新性的植入物。目前，市场上有几种类型的人工晶状体。主要分类为单焦点透镜、多焦点透镜、三焦点透镜、扩展焦深透镜和环面透镜。目的:本病例报告的目的是报告年轻白内障患者选择人工晶状体的重要性。病例报告:一位35岁的病人首次来我诊所就诊。在过去的六个月里，即使戴着眼镜，他也发现左眼视力不佳。由于年轻时出现白内障，右眼于2020年在另一家机构接受了手术。术前全面的眼科检查后，我们发现左眼有白内障。左眼UDVA为0.4,CDVA为+0.50/+0.50/30°=0.5。UNVA和DCNVA是J2。我们决定在白内障手术期间植入TECNIS Synergy™IOL (Johnson & Johnson Vision, Santa Ana, CA, USA)。EDOF人工晶状体弥补了单焦点和多焦点人工晶状体之间的差距，即使在低光条件下，也能从远到近为白内障患者提供连续的高对比度视力。无术中、术后并发症。第7天复查左眼UDVA 1.0, UNVA J1。患者对左眼视力满意，希望矫正右眼视力，右眼植入SENSAR®人工晶体(Johnson & Johnson vision, Santa Ana, CA, USA)，远视残余屈光度为+2.00/+1.00/120，近视残余屈光度为+4.50/+1.00/120。由于该患者的年龄和职业，在其他机构选择人工晶状体并不是理想的解决方案。囊袋已发生轻微纤维化，现有人工晶状体植入术不是合理的选择。我们决定使用多焦AddOn®环形晶状体(1stQ GmbH, Mannheim, Germany)，这是一种用于增强假性晶状眼视力的屈光手术平台，也可以纠正残留的散光。7天复查，UDVA为1.0,UNVA为J1。结果是一个快乐的病人，他可以回到他的日常生活，没有眼镜的独立性。结论:白内障手术和人工晶状体植入术后，良好的无辅助距离视力(VA)是一个现实的期望。我们应该了解患者的期望和要求，特别是在治疗年轻白内障患者时。通常，术前人工晶状体计划比白内障手术本身要花费更多的时间。
{"title":"The Importance of IOL Selection in Patients With Young-age Cataracts: a Case Report","authors":"Bobana Petrovic, Alma Biscevic, M. Pjano, Ajla Salkica","doi":"10.5455/ijbh.2022.10.176-182","DOIUrl":"https://doi.org/10.5455/ijbh.2022.10.176-182","url":null,"abstract":"Background: A cataract is a type of degenerative change of the lens, which is characterized by the clouding of the lens followed by symptoms of optical deterioration. Over 70 years ago, Sir Harold Ridley implanted the first useable modern-day intraocular lens (IOL) implant. A lot has happened since then. The IOL is arguably the most life-changing and innovative implant in the history of medicine. Currently, there are several types of intraocular lenses on the market. The main classification could be monofocal lenses, multifocal, trifocal, extended depth of focus (EDOF) lenses, and toric lenses. Objective: The aim of this case report is to report the importance of IOL selection in patients with young-age cataracts. Case report: A 35-year-old patient presented first time at our Clinic. In the last six months, he noticed poor vision in his left eye, even with spectacles. The right eye was operated on in another institution in 2020, due to the presence of a young-age cataract. After a complete preoperative ophthalmological examination, we discovered the presence of a cataract in the left eye. UDVA of the left eye was 0.4, and CDVA was +0.50/+0.50/30°=0.5. UNVA and DCNVA was J2. We decided to implant TECNIS Synergy™ IOL (Johnson & Johnson Vision, Santa Ana, CA, USA) during the cataract surgery. That EDOF IOL bridges the gap between the performance of monofocal and multifocal IOLs and delivers continuous high-contrast vision for patients with cataracts from far through near, even in low-light conditions. There were no intraoperative or postoperative complications. On a 7-day, check-up UDVA of the left eye was 1.0, and UNVA was J1. The patient was satisfied with the vision in the left eye, so he wanted to correct the vision of the right eye which was implanted with SENSAR® IOL (Johnson & Johnson Vision, Santa Ana, CA, USA), with a residual diopter of +2.00/+1.00/120 for distance, and +4.50/+1.00/120 for near vision. This choice of IOL in the other institution was not an ideal solution for this patient due to his young age and occupation. The capsular bag was already in slight fibrosis, so the explantation of the existing IOL and implantation of the new one was not a reasonable option. We decided to go with the multifocal AddOn® toric lens (1stQ GmbH, Mannheim, Germany), the refractive-surgery platform for vision enhancement of pseudophakic eyes, that also correct residual astigmatism. On a 7-day check-up, this patient’s UDVA was 1.0 and UNVA was J1. The result was a happy patient, who could go back to his everyday life without spectacle independence. Conclusion: Good unaided distance visual acuity (VA) is now a realistic expectation following cataract surgery and intraocular lens (IOL) implantation. We should be aware of patient expectations and demands, especially when having a patient with young-age cataracts. Often more time should be spent on preoperative IOL planning than cataract surgery itself.","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123135247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2021.9.75-80
E. Suljic, N. Mahmutbegović, A. Mehičević, Merjema Arnautovic, Dzemaluddin Mulalic, Amina Babic
{"title":"Vascular Risk Factors in Post-stroke Depression in Young Adults: a Prospective Cohort Study","authors":"E. Suljic, N. Mahmutbegović, A. Mehičević, Merjema Arnautovic, Dzemaluddin Mulalic, Amina Babic","doi":"10.5455/ijbh.2021.9.75-80","DOIUrl":"https://doi.org/10.5455/ijbh.2021.9.75-80","url":null,"abstract":"","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124518210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2022.10.183-186
Mohammad Ardat
Background: preeclampsia, a pregnancy-specific condition, is characterized by hypertension and proteinuria after 20 weeks of gestation. In addition, preeclampsia may have an impact on women’s health beyond their pregnancies, and has been associated with increased risks for future hypertension and cardiovascular disease, such as coronary heart disease and stroke. Objective: the aim of this paper was to present a case of preeclampsia with letal outcomes of mother, but child is saved by Cesarea section. Methods: presentation of a case of preeclampsia in a patient who was hospitalized at the Clinic for Gynecology and Obstetrics of the Sarajevo Canton. Cas report: the patient underwent continuous non-invasive monitoring of vital parameters. On admission TA 209/141 mmHg, HR 99/ min, SpO2 95 %, with oxygen support on a nasal catheter 4L/min. Ebrantyl 25 mg iv is prescribed immediately (measured pressure TA 191/148 mmHg), and then Ebrantyl in continuous infusion, 0.9% NaCl iv to maintain the venous path, laboratory findings are taken and the internist and neurologist are called in consultation. Upon arrival at the intensive care unit at 3:57 PM, the competent physician for the consular internal examination finds the patient unconscious, with no pressure or pulse, resuscitation in progress, guided by anesthesia. Conclusion: the conducted study proved that high blood pressure leads to preeclampsia, which in this case resulted in the death of the mother, while the baby survived.
{"title":"Preeclampsia - Case Report","authors":"Mohammad Ardat","doi":"10.5455/ijbh.2022.10.183-186","DOIUrl":"https://doi.org/10.5455/ijbh.2022.10.183-186","url":null,"abstract":"Background: preeclampsia, a pregnancy-specific condition, is characterized by hypertension and proteinuria after 20 weeks of gestation. In addition, preeclampsia may have an impact on women’s health beyond their pregnancies, and has been associated with increased risks for future hypertension and cardiovascular disease, such as coronary heart disease and stroke. Objective: the aim of this paper was to present a case of preeclampsia with letal outcomes of mother, but child is saved by Cesarea section. Methods: presentation of a case of preeclampsia in a patient who was hospitalized at the Clinic for Gynecology and Obstetrics of the Sarajevo Canton. Cas report: the patient underwent continuous non-invasive monitoring of vital parameters. On admission TA 209/141 mmHg, HR 99/ min, SpO2 95 %, with oxygen support on a nasal catheter 4L/min. Ebrantyl 25 mg iv is prescribed immediately (measured pressure TA 191/148 mmHg), and then Ebrantyl in continuous infusion, 0.9% NaCl iv to maintain the venous path, laboratory findings are taken and the internist and neurologist are called in consultation. Upon arrival at the intensive care unit at 3:57 PM, the competent physician for the consular internal examination finds the patient unconscious, with no pressure or pulse, resuscitation in progress, guided by anesthesia. Conclusion: the conducted study proved that high blood pressure leads to preeclampsia, which in this case resulted in the death of the mother, while the baby survived.","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114725420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2021.9.238-238
I. Masic
{"title":"Multiple Sclerosis and Other Demyelinating Diseases","authors":"I. Masic","doi":"10.5455/ijbh.2021.9.238-238","DOIUrl":"https://doi.org/10.5455/ijbh.2021.9.238-238","url":null,"abstract":"","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121547615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2021.9.131-132
M. Zildžić
{"title":"The Most Influential Scientists in the Development of Biomedicine: Nikolai Aleksandrovich Semashko (1874-1949)","authors":"M. Zildžić","doi":"10.5455/ijbh.2021.9.131-132","DOIUrl":"https://doi.org/10.5455/ijbh.2021.9.131-132","url":null,"abstract":"","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123929615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2019.7.113-114
L. Žunić
{"title":"The Most Influential Scientists in the Development of Biomedicine: Felix Hoffmann (1868-1946)","authors":"L. Žunić","doi":"10.5455/ijbh.2019.7.113-114","DOIUrl":"https://doi.org/10.5455/ijbh.2019.7.113-114","url":null,"abstract":"","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116910609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2021.9.236-237
Edina Redzic
{"title":"The Most Influential Scientists in the Development of Public Health: Tomas Percival (1740-1804)","authors":"Edina Redzic","doi":"10.5455/ijbh.2021.9.236-237","DOIUrl":"https://doi.org/10.5455/ijbh.2021.9.236-237","url":null,"abstract":"","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128435769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2022.10.150-154
Sevleta Avdić, E. Osmanović, D. Mršić, N. Naser, N. Kadrić, Senada Husarić, A. Salihovic
Background: A significant number of patients who underwent surgical myocardial revascularization (CABG) have various comorbidities, including left ventricular diastolic dysfunction (LVDD). Objective: The aim of this paper is to show that patients with preoperative LVDD are at an increased risk of postoperative adverse events and have a worse prognosis compared to patients without LVDD. Methods: The study included 116 patients who underwent myocardial revascularization (CABG) performed at Medical Institute Bayer in Tuzla over a period of 1 year. None of the patients had previously undergone CABG or valvular surgery, or undergone stent implantation (PCI). The presence of LV diastolic dysfunction was detected by echocardiography, and the patients were divided into two groups: with and without LVDD, and further classified into three degrees of LVDD. Results: Of the total number of subjects who underwent surgical revascularization of the myocardium without echocardiographically detected LVDD, 24.1% were patients, and 75.9% were patients with LVDD. In the group with LVDD, the range of days spent in the intensive care unit (ICU) is significantly higher compared to patients without LVDD. Also, patients with LVDD had a significantly higher number of hours of inotropic support, a significantly higher number of cases of tachycardia, predominantly atrial fibrillation (POAF). In this group of patients, a greater number of other adverse events were observed, such as myocardial infarction, cardiac or renal failure, TIA or CVI. Of the total number of patients in the study, 107 patients survived surgical myocardial revascularization and had a satisfactory recovery while 9 (7.8%) survived, all from the group with LVDD. Conclusion: Patients with preoperative diastolic dysfunction of the left ventricle, especially with III degree of dysfunction, are exposed to a higher postoperative risk of adverse events such as: atrial fibrillation, prolonged stay in the intensive care unit, the need for longer-term support with inotropes, and the fatal outcome was recorded exclusively in patients with LV diastolic dysfunction.
{"title":"Adverse Events After Surgical Myocardial Revascularization in Patients With Preoperative Left Ventricular Diastolic Dysfunction","authors":"Sevleta Avdić, E. Osmanović, D. Mršić, N. Naser, N. Kadrić, Senada Husarić, A. Salihovic","doi":"10.5455/ijbh.2022.10.150-154","DOIUrl":"https://doi.org/10.5455/ijbh.2022.10.150-154","url":null,"abstract":"Background: A significant number of patients who underwent surgical myocardial revascularization (CABG) have various comorbidities, including left ventricular diastolic dysfunction (LVDD). Objective: The aim of this paper is to show that patients with preoperative LVDD are at an increased risk of postoperative adverse events and have a worse prognosis compared to patients without LVDD. Methods: The study included 116 patients who underwent myocardial revascularization (CABG) performed at Medical Institute Bayer in Tuzla over a period of 1 year. None of the patients had previously undergone CABG or valvular surgery, or undergone stent implantation (PCI). The presence of LV diastolic dysfunction was detected by echocardiography, and the patients were divided into two groups: with and without LVDD, and further classified into three degrees of LVDD. Results: Of the total number of subjects who underwent surgical revascularization of the myocardium without echocardiographically detected LVDD, 24.1% were patients, and 75.9% were patients with LVDD. In the group with LVDD, the range of days spent in the intensive care unit (ICU) is significantly higher compared to patients without LVDD. Also, patients with LVDD had a significantly higher number of hours of inotropic support, a significantly higher number of cases of tachycardia, predominantly atrial fibrillation (POAF). In this group of patients, a greater number of other adverse events were observed, such as myocardial infarction, cardiac or renal failure, TIA or CVI. Of the total number of patients in the study, 107 patients survived surgical myocardial revascularization and had a satisfactory recovery while 9 (7.8%) survived, all from the group with LVDD. Conclusion: Patients with preoperative diastolic dysfunction of the left ventricle, especially with III degree of dysfunction, are exposed to a higher postoperative risk of adverse events such as: atrial fibrillation, prolonged stay in the intensive care unit, the need for longer-term support with inotropes, and the fatal outcome was recorded exclusively in patients with LV diastolic dysfunction.","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128185901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2022.10.121-123
M. Jusufbegović, F. Julardžija, A. Šehić, S. Vegar
Background: Spinal hydatid cyst represents a rare form of parasitic infection and is a serious clinical condition that can cause severe consequences such as paraplegia, tetraplegia, or radiculopathy. Objective: In this article, we report a case of a rare lumbar hydatid cyst in a 50-year-old man. Case presentation: We report a rare case of primary lumbar hydatid cyst. Recurrence was diagnosed by magnetic resonance imaging (MRI), although the patient had surgery and was taking albendazole regularly. Conclusion: MRI imaging should be used to diagnose the disease. Complete resection is the only treatment that can prevent the lesion from invading adjacent tissues. Regardless of all measures, the disease has a high recurrence rate.
{"title":"Recurrent Hydatid Cyst of the Head, Cervical and Lumbar Spine: a Case Report","authors":"M. Jusufbegović, F. Julardžija, A. Šehić, S. Vegar","doi":"10.5455/ijbh.2022.10.121-123","DOIUrl":"https://doi.org/10.5455/ijbh.2022.10.121-123","url":null,"abstract":"Background: Spinal hydatid cyst represents a rare form of parasitic infection and is a serious clinical condition that can cause severe consequences such as paraplegia, tetraplegia, or radiculopathy. Objective: In this article, we report a case of a rare lumbar hydatid cyst in a 50-year-old man. Case presentation: We report a rare case of primary lumbar hydatid cyst. Recurrence was diagnosed by magnetic resonance imaging (MRI), although the patient had surgery and was taking albendazole regularly. Conclusion: MRI imaging should be used to diagnose the disease. Complete resection is the only treatment that can prevent the lesion from invading adjacent tissues. Regardless of all measures, the disease has a high recurrence rate.","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132195930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.5455/ijbh.2019.7.49-50
L. Žunić
{"title":"The Most Influential Scientists in the Development of Biomedicine: Archie Cochrane","authors":"L. Žunić","doi":"10.5455/ijbh.2019.7.49-50","DOIUrl":"https://doi.org/10.5455/ijbh.2019.7.49-50","url":null,"abstract":"<jats:p />","PeriodicalId":187078,"journal":{"name":"International Journal on Biomedicine and Healthcare","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134466599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：